August 04, 2017
In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation
Case Number:
2:17-md-02785
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Burns Charest
- Law Offices of Ursula Taylor
- Foulston Siefkin
- Kaufman & Canoles
- Matthew G. Miller PC
- Gustafson Gluek
- McCune Law
- Goodwin Procter
- Butler Prather
- Spencer Fane
- Parker Waichman
- Perkins Coie
- Kramer Levin
- DiCello Levitt
- Kopelowitz Ostrow
- Siegfried & Jensen
- Bradford & Wilson
- Spragens Law
- Lathrop GPM
- Pallas Partners
- Lightfoot Franklin
- Robbins Geller
- Gibson Dunn
- Boies Schiller
- Williams & Connolly
- DLA Piper
- Fredrikson & Byron
- Reed Smith
- Barton & Burrows
- Gibbs Mura
- Lockridge Grindal
- Pritzker Levine
- Blood Hurst
- Hagens Berman
- White & Case
- Alexander Appellate Law
- Berkowitz Oliver
- Joseph Saveri Law Firm
- Wilson Sonsini
- Horn Aylward
- Dollar Burns
- Saiber LLC
- Robins Kaplan
- Shook Hardy
- Hogan Lovells
- Goldman Scarlato
- Robbins Russell
- Sidley Austin
- Roberts Law Firm US
- Holland & Knight
- Whiteford Taylor
- Squitieri & Fearon
- Hinkle Law Firm
- Willkie Farr
- Foley & Lardner
- Carella Byrne
- King & Spalding
- Lanier Law Firm
- Strategic Health Law
- Keller Rohrback
- Weil Gotshal
- Groom Law Group
- Nussbaum Law Group
- Barnow and Associates
- Marion's Inn
- Bush Seyferth
- Wagstaff & Cartmell
- Mehri & Skalet
- Wallace Saunders
- Lowey Dannenberg
- Steven Williams Law
- Levi & Korsinsky
- Beasley Allen
- Berman Tabacco
- Ali & Lockwood
- Clark Hill
- GM Law PC
- Baron & Budd
- Orrick Herrington
- HSF Kramer
- Mayer Brown
Companies
- Amerigroup Corp.
- Change Healthcare Inc.
- MedImpact Healthcare Systems Inc.
- Humana Inc.
- Blue Cross Blue Shield Association
- Meridian Medical Technologies Inc.
- Coventry Health Care Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- The Segal Co. Inc.
- Viatris Inc.
- UnitedHealth Group Inc.
- Aetna Inc.
- OptumRx Inc.
- Centene Corp.
- King Pharmaceuticals Inc.
- Optum Inc.
- Sanofi
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 14, 2022
Judge OKs $264M Deal Ending Mylan EpiPen Price-Hike Suit
A Kansas federal court has preliminarily approved a $264 million deal that would end claims that Mylan colluded with Pfizer Inc. to obstruct generic versions of the EpiPen, the emergency drug used to treat severe allergic reactions, from entering the market.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login